menu
    • menu

    Company profile for AccurEdit Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    AccurEdit is a biotechnology company dedicated to developing and commercializing safe, effective, and targeted in vivo gene editing therapies for hereditary and acquired diseases. With an industry-leading end-to-end technology platform, AccurEdit specializes in RNA synthesis, editing, and delivery technologies. In October 2023, it became the first and only company in China to demonstrate safe and effective systemic CRISPR gene...
    AccurEdit is a biotechnology company dedicated to developing and commercializing safe, effective, and targeted in vivo gene editing therapies for hereditary and acquired diseases. With an industry-leading end-to-end technology platform, AccurEdit specializes in RNA synthesis, editing, and delivery technologies. In October 2023, it became the first and only company in China to demonstrate safe and effective systemic CRISPR gene editing in humans. Committed to patient-centric innovation, AccurEdit aims to deliver single-dose curative therapies through its highly efficient platform.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AccurEdit TherapeuticsChina Flag
    Country
    Country
    China
    Address
    Address
    Unit 201, Building B6, Phase I, Biomedicine Industrial Park, No. 218 Xinghu St...
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.accuredit.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ART001 Becomes First Gene Editing Therapy to Get RMAT in China
    ART001 Becomes First Gene Editing Therapy to Get RMAT in China

    28 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/accuredit-therapeutics-art001-becomes-chinas-first-gene-editing-therapy-to-receive-fda-regenerative-medicine-advanced-therapy-rmat-designation-302468037.html

    PR NEWSWIRE
    28 May 2025
    Share Share
    AccurEdit Therapeutics' ART001 Obtains FDA Orphan Drug Designation
    AccurEdit Therapeutics' ART001 Obtains FDA Orphan Drug Designation

    25 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/accuredit-therapeutics-lnp-based-in-vivo-gene-editing-product-art001-obtained-orphan-drug-designation-from-the-fda-302410518.html

    PR NEWSWIRE
    25 Mar 2025
    Share Share
    Accuredit Therapeutics and N1 Life Form JV Named 'Napoltec'
    Accuredit Therapeutics and N1 Life Form JV Named 'Napoltec'

    13 Jan 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/accuredit-therapeutics-and-n1-life-form-a-joint-venture-named-napoltec-dedicated-to-the-development-of-therapeutic-drug-delivery-systems-and-pressing-ahead-clinical-translation-301460130.html

    PRNEWSWIRE
    13 Jan 2022
    Share Share
    Accuredit Therapeutics Appointed Dr. Fuxin Shi as Head of New Drug Discovery
    Accuredit Therapeutics Appointed Dr. Fuxin Shi as Head of New Drug Discovery

    29 Nov 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/accuredit-therapeutics-appointed-dr-fuxin-shi-as-head-of-new-drug-discovery--preclinical-research-and-general-manager-of-the-us-subsidiary-301432626.html

    PRNEWSWIRE
    29 Nov 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search